These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 27110777

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
    Kang JH, Ko HM, Moon JS, Yoo HI, Jung JY, Kim MS, Koh JT, Kim WJ, Kim SH.
    J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Osteoprotegerin influences the bone resorption activity of osteoclasts.
    Fu YX, Gu JH, Zhang YR, Tong XS, Zhao HY, Yuan Y, Liu XZ, Bian JC, Liu ZP.
    Int J Mol Med; 2013 Jun; 31(6):1411-7. PubMed ID: 23563320
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY.
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [Abstract] [Full Text] [Related]

  • 29. Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.
    Liu XH, Kirschenbaum A, Yao S, Levine AC.
    Endocrinology; 2005 Apr; 146(4):1991-8. PubMed ID: 15618359
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. RANKL subcellular trafficking and regulatory mechanisms in osteocytes.
    Honma M, Ikebuchi Y, Kariya Y, Hayashi M, Hayashi N, Aoki S, Suzuki H.
    J Bone Miner Res; 2013 Sep; 28(9):1936-49. PubMed ID: 23529793
    [Abstract] [Full Text] [Related]

  • 35. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H.
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [Abstract] [Full Text] [Related]

  • 36. (-)-Epigallocatechin-3-Gallate Decreases Osteoclastogenesis via Modulation of RANKL and Osteoprotegrin.
    Chen ST, Kang L, Wang CZ, Huang PJ, Huang HT, Lin SY, Chou SH, Lu CC, Shen PC, Lin YS, Chen CH.
    Molecules; 2019 Jan 03; 24(1):. PubMed ID: 30609798
    [Abstract] [Full Text] [Related]

  • 37. Regulation of OPG and RANKL expressed by human dental follicle cells in osteoclastogenesis.
    Sun H, Li Q, Zhang Y, Bi Y, Li X, Shu Y, Chen X, Jin Z, Ge C.
    Cell Tissue Res; 2015 Nov 03; 362(2):399-405. PubMed ID: 26149648
    [Abstract] [Full Text] [Related]

  • 38. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis.
    Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S.
    Arthritis Rheum; 2000 Feb 03; 43(2):259-69. PubMed ID: 10693864
    [Abstract] [Full Text] [Related]

  • 39. Pulsed electromagnetic fields stimulation affects osteoclast formation by modulation of osteoprotegerin, RANK ligand and macrophage colony-stimulating factor.
    Chang K, Chang WH, Huang S, Huang S, Shih C.
    J Orthop Res; 2005 Nov 03; 23(6):1308-14. PubMed ID: 15913941
    [Abstract] [Full Text] [Related]

  • 40. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells.
    Kondo H, Guo J, Bringhurst FR.
    J Bone Miner Res; 2002 Sep 03; 17(9):1667-79. PubMed ID: 12211438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.